Insider Transactions in Q1 2021 at Concert Pharmaceuticals, Inc. (CNCE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2021
|
Roger D Tung Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,480
-1.64%
|
$94,360
$7.2 P/Share
|
|
Feb 16
2021
|
Marc A. Becker Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,763
-5.01%
|
$26,341
$7.32 P/Share
|
|
Feb 16
2021
|
James V Cassella Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,763
-3.85%
|
$26,341
$7.32 P/Share
|
|
Feb 16
2021
|
Jeffrey A Munsie Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,763
-7.54%
|
$26,341
$7.32 P/Share
|
|
Feb 16
2021
|
Nancy Stuart Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,049
-3.37%
|
$42,343
$7.32 P/Share
|
|
Jan 05
2021
|
Marc A. Becker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+22.41%
|
-
|
|
Jan 05
2021
|
James V Cassella Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+18.15%
|
-
|
|
Jan 05
2021
|
Jeffrey A Munsie Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+30.3%
|
-
|
|
Jan 05
2021
|
Nancy Stuart Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+10.79%
|
-
|
|
Jan 05
2021
|
Roger D Tung Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,300
+7.77%
|
-
|